Period,symbol,NAV,sharesOutstanding,researchDevelopment,effectOfAccountingCharges,incomeBeforeTax,minorityInterest,netIncome,sellingGeneralAdministrative,grossProfit,ebit,operatingIncome,otherOperatingExpenses,interestExpense,extraordinaryItems,nonRecurring,otherItems,incomeTaxExpense,totalRevenue,totalOperatingExpenses,costOfRevenue,totalOtherIncomeExpenseNet,discontinuedOperations,netIncomeFromContinuingOps,netIncomeApplicableToCommonShares,capitalSurplus,totalLiab,totalStockholderEquity,deferredLongTermLiab,otherCurrentLiab,totalAssets,commonStock,retainedEarnings,otherLiab,otherAssets,cash,totalCurrentLiabilities,propertyPlantEquipment,totalCurrentAssets,netReceivables,longTermDebt,inventory,accountsPayable,changeToLiabilities,totalCashflowsFromInvestingActivities,netBorrowings,totalCashFromFinancingActivities,changeToOperatingActivities,changeInCash,totalCashFromOperatingActivities,depreciation,otherCashflowsFromInvestingActivities,changeToInventory,changeToAccountReceivables,otherCashflowsFromFinancingActivities,changeToNetincome,capitalExpenditures,WC,language,region,quoteType,triggerable,quoteSourceName,regularMarketChangePercent,regularMarketDayRange,regularMarketPreviousClose,messageBoardId,fullExchangeName,longName,financialCurrency,averageDailyVolume3Month,averageDailyVolume10Day,fiftyTwoWeekLowChange,fiftyTwoWeekLowChangePercent,fiftyTwoWeekRange,fiftyTwoWeekHighChange,fiftyTwoWeekHighChangePercent,fiftyTwoWeekLow,fiftyTwoWeekHigh,epsTrailingTwelveMonths,currency,priceHint,bookValue,fiftyDayAverage,fiftyDayAverageChange,fiftyDayAverageChangePercent,twoHundredDayAverage,twoHundredDayAverageChange,twoHundredDayAverageChangePercent,marketCap,priceToBook,sourceInterval,exchangeTimezoneName,exchangeTimezoneShortName,gmtOffSetMilliseconds,exchange,exchangeDataDelayedBy,esgPopulated,tradeable,regularMarketPrice,regularMarketTime,regularMarketChange,regularMarketOpen,regularMarketDayHigh,regularMarketDayLow,regularMarketVolume,shortName,market,marketState,Beta (5Y Monthly),52-Week Change 3,S&P500 52-Week Change 3,52 Week High 3,52 Week Low 3,50-Day Moving Average 3,200-Day Moving Average 3,Avg Vol (3 month) 3,Avg Vol (10 day) 3,Shares Outstanding 5,Implied Shares Outstanding 6,Float,% Held by Insiders 1,% Held by Institutions 1,"Shares Short (Apr 09, 2003) 4","Short Ratio (Apr 09, 2003) 4","Short % of Float (Apr 09, 2003) 4","Short % of Shares Outstanding (Apr 09, 2003) 4","Shares Short (prior month Feb 10, 2003) 4",Forward Annual Dividend Rate 4,Forward Annual Dividend Yield 4,Trailing Annual Dividend Rate 3,Trailing Annual Dividend Yield 3,5 Year Average Dividend Yield 4,Payout Ratio 4,Dividend Date 3,Ex-Dividend Date 4,Last Split Factor 2,Last Split Date 3,Fiscal Year Ends,Most Recent Quarter (mrq),Profit Margin,Operating Margin (ttm),Return on Assets (ttm),Return on Equity (ttm),Revenue (ttm),Revenue Per Share (ttm),Quarterly Revenue Growth (yoy),Gross Profit (ttm),EBITDA,Net Income Avi to Common (ttm),Diluted EPS (ttm),Quarterly Earnings Growth (yoy),Total Cash (mrq),Total Cash Per Share (mrq),Total Debt (mrq),Total Debt/Equity (mrq),Current Ratio (mrq),Book Value Per Share (mrq),Operating Cash Flow (ttm),Levered Free Cash Flow (ttm),index,zip,sector,longBusinessSummary,city,phone,state,compensationAsOfEpochDate,country,website,maxAge,address1,industry,address2
t0,HDII,-1434869,52388800,,,-478897,,-628578,188237,-183709,-371946,-371946,,-106951,,,,0,821,372767,184530,-106951,-149681,-478897,-628578,28723460,2493694,-1434869,6150,155000,1064939,523887,-30682216,280643,56278,5664,1134365,731915,276746,117066,1043184,140486,437690,90375,-99342,327780,322780,84258,5263,-218175,44670,75000,-12878,15636,-5000,135994,-174342,-857619,en-US,US,EQUITY,False,Delayed Quote,-7.0312457,0.0112 - 0.0119,0.0128,finmb_389709,Other OTC,"Hypertension Diagnostics, Inc.",USD,866527,2228399,0.0037000002,0.45121953,0.0082 - 0.125,-0.1131,-0.9048,0.0082,0.125,-0.002,USD,4,-0.091,0.014821389,-0.0029213885,-0.19710626,0.020494545,-0.008594545,-0.41935766,623426,-0.13076924,15,America/New_York,EDT,-14400000,PNK,0,False,False,0.0119,1630520301,-0.0008999994,0.0119,0.0119,0.0112,341286,HYPERTENSION DIAGNOSTICS INCORP,us_market,PRE,-3.35,,,0.125,0.0082,0.0148,0.0205,866.53k,2.23M,52.39M,,,0.00%,0.00%,,0,,0.00%,12.05k,,,,,,0.00%,,,,,"Dec 30, 2018","Mar 30, 2013",-3.31%,0.02%,0.03%,,3.79M,0.07,-100.00%,954.47k,36.71k,-125.39k,-0.0020,,5.66k,0,1.3M,,0.52,-0.09,-389.28k,-432k,Value,L4B 3Z4,Industrials,"Hypertension Diagnostics, Inc. designs, develops, manufactures, and markets proprietary noninvasive medical devices that detect subtle changes in the elasticity of arteries in the United States and internationally. It offers CVProfilor, which allows a physician to non-invasively assess the elasticity of small and large arteries, of which small artery elasticity is the earliest and sensitive marker of cardiovascular disease. The company offers CVProfilor DO-2020, which provides a patient's arterial elasticity indices used in the assessment for underlying vascular disease; CVProfilor MD-3000 that offers a sensitive and specific guide to the presence of blood vessel disease; and HD/PulseWave CR-2000 research cardiovascular profiling system, which provides researchers and scientists with a non-invasive means to assess arterial elasticity in support of human research in various areas. Its products collect 30 seconds of blood pressure waveform data, perform an analysis of the digitized blood pressure waveforms, and generate a CVProfile report that contains information on blood pressure, heart rate, pulse pressure, body surface area, body mass index, and C1-large and C2-small artery elasticity indices. The company sells its products to primary care physicians, cardiologists, health care professionals, trained medical personnel, research investigators at academic medical research centers, government institutes, cardiovascular specialists, and pharmaceutical firms. It markets its products through a representative organization in the United States. Hypertension Diagnostics, Inc. was founded in 1988 and is based in Richmond Hill, Canada.",Richmond Hill,404-449-6151,ON,1199059200,Canada,http://www.hypertensiondiagnostics.com,86400,550 Highway 7 East,Waste Management,Unit 316
t-1,HDII,-903108,52388800,,,-442237,,-42500,115841,-244865,-360706,-360706,,-80038,,,,0,13437,374143,258302,-81531,399737,-442237,-42500,28626643,1901144,-903108,6560,155000,1004150,523887,-30053638,144649,55717,401,798816,595743,352690,207702,911366,127608,345251,79246,-64642,244259,244259,-10831,-76874,-256491,36813,75000,57231,-6139,-5000,-404926,-64642,-446126,en-US,US,EQUITY,False,Delayed Quote,-7.0312457,0.0112 - 0.0119,0.0128,finmb_389709,Other OTC,"Hypertension Diagnostics, Inc.",USD,866527,2228399,0.0037000002,0.45121953,0.0082 - 0.125,-0.1131,-0.9048,0.0082,0.125,-0.002,USD,4,-0.091,0.014821389,-0.0029213885,-0.19710626,0.020494545,-0.008594545,-0.41935766,623426,-0.13076924,15,America/New_York,EDT,-14400000,PNK,0,False,False,0.0119,1630520301,-0.0008999994,0.0119,0.0119,0.0112,341286,HYPERTENSION DIAGNOSTICS INCORP,us_market,PRE,-3.35,,,0.125,0.0082,0.0148,0.0205,866.53k,2.23M,52.39M,,,0.00%,0.00%,,0,,0.00%,12.05k,,,,,,0.00%,,,,,"Dec 30, 2018","Mar 30, 2013",-3.31%,0.02%,0.03%,,3.79M,0.07,-100.00%,954.47k,36.71k,-125.39k,-0.0020,,5.66k,0,1.3M,,0.52,-0.09,-389.28k,-432k,Value,L4B 3Z4,Industrials,"Hypertension Diagnostics, Inc. designs, develops, manufactures, and markets proprietary noninvasive medical devices that detect subtle changes in the elasticity of arteries in the United States and internationally. It offers CVProfilor, which allows a physician to non-invasively assess the elasticity of small and large arteries, of which small artery elasticity is the earliest and sensitive marker of cardiovascular disease. The company offers CVProfilor DO-2020, which provides a patient's arterial elasticity indices used in the assessment for underlying vascular disease; CVProfilor MD-3000 that offers a sensitive and specific guide to the presence of blood vessel disease; and HD/PulseWave CR-2000 research cardiovascular profiling system, which provides researchers and scientists with a non-invasive means to assess arterial elasticity in support of human research in various areas. Its products collect 30 seconds of blood pressure waveform data, perform an analysis of the digitized blood pressure waveforms, and generate a CVProfile report that contains information on blood pressure, heart rate, pulse pressure, body surface area, body mass index, and C1-large and C2-small artery elasticity indices. The company sells its products to primary care physicians, cardiologists, health care professionals, trained medical personnel, research investigators at academic medical research centers, government institutes, cardiovascular specialists, and pharmaceutical firms. It markets its products through a representative organization in the United States. Hypertension Diagnostics, Inc. was founded in 1988 and is based in Richmond Hill, Canada.",Richmond Hill,404-449-6151,ON,1199059200,Canada,http://www.hypertensiondiagnostics.com,86400,550 Highway 7 East,Waste Management,Unit 316
t-2,HDII,-915855,52388800,,,-447957,,-729837,201024,-111457,-312481,-312481,,-58559,,,,0,34622,347103,146079,-135476,-281880,-447957,-729837,28571396,2029297,-915855,6560,155000,1119556,523887,-30011138,552631,55717,77275,717575,573789,490050,201563,702442,184839,268069,97237,-11232,177028,177028,-23834,2232,-163564,35176,75000,-12616,99993,-5000,348905,-11232,-227525,en-US,US,EQUITY,False,Delayed Quote,-7.0312457,0.0112 - 0.0119,0.0128,finmb_389709,Other OTC,"Hypertension Diagnostics, Inc.",USD,866527,2228399,0.0037000002,0.45121953,0.0082 - 0.125,-0.1131,-0.9048,0.0082,0.125,-0.002,USD,4,-0.091,0.014821389,-0.0029213885,-0.19710626,0.020494545,-0.008594545,-0.41935766,623426,-0.13076924,15,America/New_York,EDT,-14400000,PNK,0,False,False,0.0119,1630520301,-0.0008999994,0.0119,0.0119,0.0112,341286,HYPERTENSION DIAGNOSTICS INCORP,us_market,PRE,-3.35,,,0.125,0.0082,0.0148,0.0205,866.53k,2.23M,52.39M,,,0.00%,0.00%,,0,,0.00%,12.05k,,,,,,0.00%,,,,,"Dec 30, 2018","Mar 30, 2013",-3.31%,0.02%,0.03%,,3.79M,0.07,-100.00%,954.47k,36.71k,-125.39k,-0.0020,,5.66k,0,1.3M,,0.52,-0.09,-389.28k,-432k,Value,L4B 3Z4,Industrials,"Hypertension Diagnostics, Inc. designs, develops, manufactures, and markets proprietary noninvasive medical devices that detect subtle changes in the elasticity of arteries in the United States and internationally. It offers CVProfilor, which allows a physician to non-invasively assess the elasticity of small and large arteries, of which small artery elasticity is the earliest and sensitive marker of cardiovascular disease. The company offers CVProfilor DO-2020, which provides a patient's arterial elasticity indices used in the assessment for underlying vascular disease; CVProfilor MD-3000 that offers a sensitive and specific guide to the presence of blood vessel disease; and HD/PulseWave CR-2000 research cardiovascular profiling system, which provides researchers and scientists with a non-invasive means to assess arterial elasticity in support of human research in various areas. Its products collect 30 seconds of blood pressure waveform data, perform an analysis of the digitized blood pressure waveforms, and generate a CVProfile report that contains information on blood pressure, heart rate, pulse pressure, body surface area, body mass index, and C1-large and C2-small artery elasticity indices. The company sells its products to primary care physicians, cardiologists, health care professionals, trained medical personnel, research investigators at academic medical research centers, government institutes, cardiovascular specialists, and pharmaceutical firms. It markets its products through a representative organization in the United States. Hypertension Diagnostics, Inc. was founded in 1988 and is based in Richmond Hill, Canada.",Richmond Hill,404-449-6151,ON,1199059200,Canada,http://www.hypertensiondiagnostics.com,86400,550 Highway 7 East,Waste Management,Unit 316
t-3,HDII,-294783,52388800,,,-568268,,-43203,164957,-291676,-514535,-514535,53577.0,-55321,,,,0,118446,632981,410122,-53733,525065,-568268,-43203,28462631,1594482,-294783,7380,173143,1305813,523887,-29281301,262500,51037,75043,654834,678331,576445,297875,610615,172223,170832,-31221,125000,-638081,-646281,9219,-307052,214229,39634,125000,-29689,941822,-8200,-687856,-11232,-78389,en-US,US,EQUITY,False,Delayed Quote,-7.0312457,0.0112 - 0.0119,0.0128,finmb_389709,Other OTC,"Hypertension Diagnostics, Inc.",USD,866527,2228399,0.0037000002,0.45121953,0.0082 - 0.125,-0.1131,-0.9048,0.0082,0.125,-0.002,USD,4,-0.091,0.014821389,-0.0029213885,-0.19710626,0.020494545,-0.008594545,-0.41935766,623426,-0.13076924,15,America/New_York,EDT,-14400000,PNK,0,False,False,0.0119,1630520301,-0.0008999994,0.0119,0.0119,0.0112,341286,HYPERTENSION DIAGNOSTICS INCORP,us_market,PRE,-3.35,,,0.125,0.0082,0.0148,0.0205,866.53k,2.23M,52.39M,,,0.00%,0.00%,,0,,0.00%,12.05k,,,,,,0.00%,,,,,"Dec 30, 2018","Mar 30, 2013",-3.31%,0.02%,0.03%,,3.79M,0.07,-100.00%,954.47k,36.71k,-125.39k,-0.0020,,5.66k,0,1.3M,,0.52,-0.09,-389.28k,-432k,Value,L4B 3Z4,Industrials,"Hypertension Diagnostics, Inc. designs, develops, manufactures, and markets proprietary noninvasive medical devices that detect subtle changes in the elasticity of arteries in the United States and internationally. It offers CVProfilor, which allows a physician to non-invasively assess the elasticity of small and large arteries, of which small artery elasticity is the earliest and sensitive marker of cardiovascular disease. The company offers CVProfilor DO-2020, which provides a patient's arterial elasticity indices used in the assessment for underlying vascular disease; CVProfilor MD-3000 that offers a sensitive and specific guide to the presence of blood vessel disease; and HD/PulseWave CR-2000 research cardiovascular profiling system, which provides researchers and scientists with a non-invasive means to assess arterial elasticity in support of human research in various areas. Its products collect 30 seconds of blood pressure waveform data, perform an analysis of the digitized blood pressure waveforms, and generate a CVProfile report that contains information on blood pressure, heart rate, pulse pressure, body surface area, body mass index, and C1-large and C2-small artery elasticity indices. The company sells its products to primary care physicians, cardiologists, health care professionals, trained medical personnel, research investigators at academic medical research centers, government institutes, cardiovascular specialists, and pharmaceutical firms. It markets its products through a representative organization in the United States. Hypertension Diagnostics, Inc. was founded in 1988 and is based in Richmond Hill, Canada.",Richmond Hill,404-449-6151,ON,1199059200,Canada,http://www.hypertensiondiagnostics.com,86400,550 Highway 7 East,Waste Management,Unit 316
